CEMTREX INC (CETX)

US15130G7097 - Common Stock

0.176  -0.01 (-4.09%)

After market: 0.177 +0 (+0.57%)

Fundamental Rating

2

Overall CETX gets a fundamental rating of 2 out of 10. We evaluated CETX against 124 industry peers in the Electronic Equipment, Instruments & Components industry. CETX may be in some trouble as it scores bad on both profitability and health. CETX has a decent growth rate and is not valued too expensively.



1

1. Profitability

1.1 Basic Checks

CETX had negative earnings in the past year.
CETX had a negative operating cash flow in the past year.
In the past 5 years CETX always reported negative net income.
In the past 5 years CETX reported 4 times negative operating cash flow.

1.2 Ratios

CETX has a Return On Assets of -30.03%. This is in the lower half of the industry: CETX underperforms 78.05% of its industry peers.
Looking at the Return On Equity, with a value of -27445.77%, CETX is doing worse than 98.37% of the companies in the same industry.
Industry RankSector Rank
ROA -30.03%
ROE -27445.77%
ROIC N/A
ROA(3y)-20.93%
ROA(5y)-26.96%
ROE(3y)-83.87%
ROE(5y)-80.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CETX has a better Gross Margin (40.91%) than 70.73% of its industry peers.
In the last couple of years the Gross Margin of CETX has grown nicely.
The Profit Margin and Operating Margin are not available for CETX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 40.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.26%
GM growth 5Y3.58%

1

2. Health

2.1 Basic Checks

CETX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CETX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CETX has more shares outstanding
CETX has a worse debt/assets ratio than last year.

2.2 Solvency

CETX has an Altman-Z score of -0.90. This is a bad value and indicates that CETX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.90, CETX is doing worse than 76.42% of the companies in the same industry.
CETX has a Debt/Equity ratio of 352.23. This is a high value indicating a heavy dependency on external financing.
CETX's Debt to Equity ratio of 352.23 is on the low side compared to the rest of the industry. CETX is outperformed by 98.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 352.23
Debt/FCF N/A
Altman-Z -0.9
ROIC/WACCN/A
WACC4.5%

2.3 Liquidity

CETX has a Current Ratio of 1.89. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.89, CETX is not doing good in the industry: 68.29% of the companies in the same industry are doing better.
CETX has a Quick Ratio of 1.35. This is a normal value and indicates that CETX is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.35, CETX is not doing good in the industry: 65.85% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.89
Quick Ratio 1.35

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.89% over the past year.
The Revenue has grown by 16.62% in the past year. This is quite good.
CETX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.31% yearly.
EPS 1Y (TTM)69.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.77%
Revenue 1Y (TTM)16.62%
Revenue growth 3Y10.92%
Revenue growth 5Y21.31%
Sales Q2Q%-0.27%

3.2 Future

CETX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.10% yearly.
CETX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 16.02% yearly.
EPS Next Y99.69%
EPS Next 2Y41.47%
EPS Next 3Y26.1%
EPS Next 5YN/A
Revenue Next Year18.09%
Revenue Next 2Y16.53%
Revenue Next 3Y16.02%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CETX. In the last year negative earnings were reported.
CETX is valuated cheaply with a Price/Forward Earnings ratio of 0.31.
Based on the Price/Forward Earnings ratio, CETX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
CETX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.40.
Industry RankSector Rank
PE N/A
Fwd PE 0.31

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CETX's earnings are expected to grow with 26.10% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.47%
EPS Next 3Y26.1%

0

5. Dividend

5.1 Amount

CETX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CEMTREX INC

NASDAQ:CETX (11/15/2024, 8:00:00 PM)

After market: 0.177 +0 (+0.57%)

0.176

-0.01 (-4.09%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.50M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.31
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -30.03%
ROE -27445.77%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 40.92%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity 352.23
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.89
Quick Ratio 1.35
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)69.89%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y99.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)16.62%
Revenue growth 3Y10.92%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y